A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents

Lipids Health Dis. 2021 Sep 29;20(1):118. doi: 10.1186/s12944-021-01553-2.

Abstract

Background: The present study was aimed to establish a prediction model for in-stent restenosis (ISR) in subjects who had undergone percutaneous coronary intervention (PCI) with drug-eluting stents (DESs).

Materials and methods: A retrospective cohort study was conducted. From September 2010 to September 2013, we included 968 subjects who had received coronary follow-up angiography after primary PCI. The logistic regression analysis, receiver operator characteristic (ROC) analysis, nomogram analysis, Hosmer-Lemeshow χ2 statistic, and calibration curve were applied to build and evaluate the prediction model.

Results: Fifty-six patients (5.79%) occurred ISR. The platelet distribution width (PDW), total cholesterol (TC), systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDL-C), and lesion vessels had significant differences between ISR and non-ISR groups (all P < 0.05). And these variables were independently associated with ISR (all P < 0.05). Furthermore, they were identified as predictors (all AUC > 0.5 and P < 0.05) to establish a prediction model. The prediction model showed a good value of area under curve (AUC) (95%CI): 0.72 (0.64-0.80), and its optimized cut-off was 6.39 with 71% sensitivity and 65% specificity to predict ISR.

Conclusion: The incidence of ISR is 5.79% in CAD patients with DES implantation in the Xinjiang population, China. The prediction model based on PDW, SBP, TC, LDL-C, and lesion vessels was an effective model to predict ISR in CAD patients with DESs implantation.

Keywords: Coronary heart disease; In-stent restenosis; Percutaneous coronary intervention; Risk factors.

MeSH terms

  • Aged
  • Angiography / methods
  • Blood Platelets / metabolism*
  • Calibration
  • Coronary Artery Disease / blood*
  • Coronary Artery Disease / diagnosis
  • Coronary Restenosis
  • Drug-Eluting Stents / adverse effects*
  • Female
  • Humans
  • Lipids / blood*
  • Male
  • Middle Aged
  • Models, Statistical
  • Multivariate Analysis
  • Nomograms
  • ROC Curve
  • Regression Analysis
  • Retrospective Studies
  • Risk

Substances

  • Lipids